U1 Bio
San Francisco, US · Founded 2021 · Delaware corporation
Founders & leadership
U1 Bio was founded in 2021 by David Nelles.
DN
David NellesDirector and CEO
KC
Konstantinos CharizanisCOO and Director
Reported raises · per SEC filings
Form D private placements$9.9M disclosed across 2 rounds · 2021–2022
▶$9.5MraisedJun 2022 · 26 investors · BiotechnologyRule 506(b)
▶$9.5MraisedJun 2022 · 26 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Konstantinos CharizanisExecutive Officer, Director
- Sharam Seyedin-NoorDirector
- David NellesExecutive Officer, Director
- Offering amount
- $10.7M
- Amount sold
- $9.5M
- Minimum investment
- $25K
- First sale
- May 2022
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$450KraisedMar 2021 · 9 investors · BiotechnologyRule 506(b)
▶$450KraisedMar 2021 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Konstantinos CharizanisExecutive Officer, Director
- David NellesExecutive Officer, Director
- Offering amount
- $650K
- Amount sold
- $450K
- Minimum investment
- $25K
- First sale
- Mar 2021
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded U1 Bio?
- U1 Bio was founded by David Nelles in 2021.
- How much funding has U1 Bio raised?
- U1 Bio has disclosed $9.9M raised across 2 rounds.
- Where is U1 Bio headquartered?
- U1 Bio is headquartered in San Francisco, US.